![Dominik Mueller](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Dominik Mueller
Plus aucun poste en cours
Profil
Dominik Mueller is the founder of OMEICOS Therapeutics GmbH, which was founded in 2013.
Anciens postes connus de Dominik Mueller
Sociétés | Poste | Fin |
---|---|---|
OMEICOS Therapeutics GmbH
![]() OMEICOS Therapeutics GmbH BiotechnologyHealth Technology OMEICOS Therapeutics GmbH develops small molecules using endogenous protective mechanism for the treatment and prevention of atrial fibrillation. It operates as a biopharmaceutical company developing molecule therapeutics for the prevention and treatment of cardiovascular diseases including atrial fibrillation. The company was founded by Wolf-Hagen Schunck, John R. Falck, Dominik Müller, Robert Fischer and Karen Uhlmann in 2013 and is headquartered in Berlin, Germany. | Fondateur | - |
Expériences
Fonctions occupées
Sociétés liées
Entreprise privées | 1 |
---|---|
OMEICOS Therapeutics GmbH
![]() OMEICOS Therapeutics GmbH BiotechnologyHealth Technology OMEICOS Therapeutics GmbH develops small molecules using endogenous protective mechanism for the treatment and prevention of atrial fibrillation. It operates as a biopharmaceutical company developing molecule therapeutics for the prevention and treatment of cardiovascular diseases including atrial fibrillation. The company was founded by Wolf-Hagen Schunck, John R. Falck, Dominik Müller, Robert Fischer and Karen Uhlmann in 2013 and is headquartered in Berlin, Germany. | Health Technology |